HIV mutation literature information.


  Development of a didanosine genotypic resistance interpretation system based on large derivation and validation datasets.
 PMID: 19864933       2010       AIDS (London, England)
Abstract: RESULTS: The ddI resistance mutations and their resistance scores based on the derivation set were as follows: M41L (score of 14), T69D (24), D123S (40), T139M (54), I180V (53), M184V (-12), V189I (55), Q207K (37), L210W (25), and T215Y (eight).


  Level of viral load and antiretroviral resistance after 6 months of non-nucleoside reverse transcriptase inhibitor first-line treatment in HIV-1-infected children in Mali.
 PMID: 19933171       2010       The Journal of antimicrobial chemotherapy
Abstract: Among the children with detectable VL, 30/37 genotypic resistance tests were available, 8 with wild-type viruses and 22 with resistance mutations (73%): 19 M184V/I, 21 NNRTI mutations and only 3 thymidine analogue mutations (TAMs) (K70R, D67N and L210W in three distinct viruses).


  Low-abundance HIV species and their impact on mutational profiles in patients with virological failure on once-daily abacavir/lamivudine/zidovudine and tenofovir.
 PMID: 20008905       2010       The Journal of antimicrobial chemotherapy
Introduction: M41L, D67N, K70R, L210W, T215F/Y and K219Q/E), such that they are rarely detected in vivo in the same sample by popul
Table: L210L/W
Table: L210W


  N348I in HIV-1 reverse transcriptase decreases susceptibility to tenofovir and etravirine in combination with other resistance mutations.
 PMID: 20010074       2010       AIDS (London, England)
Introduction: N348I also increased tenofovir resistance when combined with M41L, L210W and T215Y (HX/3AZT) by 6.0-fold compared to WT (p= 0.009, n=5) and 3-fold compared to the HX/3AZT strain (p=0.008, n=4).
Introduction: N348I was introduced by site directed mutagenesis into the background of wild-type (WT), K103N, Y181C, M41L/L210Y and Introduction: According to the International AIDS Society-USA drug resistance mutations update, the presence of 3 or more TAMs inclusive of M41L and L210W is expected to give a reduced in vivo response to tenofovir.


  Impact of low abundance HIV variants on response to ritonavir-boosted atazanavir or fosamprenavir given once daily with tenofovir/emtricitabine in antiretroviral-naive HIV-infected patients.
 PMID: 20380480       2010       AIDS research and human retroviruses
Abstract: In the four FPV/r-treated VFs, baseline HIV TAMs combinations and/or PI mutations were detected in one by PG at VF (RT: L210W + T215C; PR: M46I + L76V) and three others by CA alone (RT: L210W + T215Y; RT: M41L; RT: K65R + K70R; PR: I47V); all four had study drug-associated mutations (CA detecting more HIV-1 resistance mut


  Constrained patterns of covariation and clustering of HIV-1 non-nucleoside reverse transcriptase inhibitor resistance mutations.
 PMID: 20462946       2010       The Journal of antimicrobial chemotherapy
Method: We also examined the extent to which the 52 NNRTI-selected mutations covaried with mutations at 12 major nucleoside reverse transcriptase inhibitor (NRTI) resistance positions, including M41L, K65R, D67N, T69S_SS, K70E, K70R, L74V, L74I, V75M/T, Y115F, Q151M, M184V/I, L210W, T215F and T215Y.
Result: The NNRTI


  Prevalence and clinical significance of HIV drug resistance mutations by ultra-deep sequencing in antiretroviral-naive subjects in the CASTLE study.
 PMID: 20532178       2010       PloS one
Table: L210W


  Drug resistance is widespread among children who receive long-term antiretroviral treatment at a rural Tanzanian hospital.
 PMID: 20576637       2010       The Journal of antimicrobial chemotherapy
Table: L210W


  Dynamics of HIV-1 quasispecies during antiviral treatment dissected using ultra-deep pyrosequencing.
 PMID: 20628644       2010       PloS one
Introduction: This region includes the following important and well-defined drug resistance mutations to nucleoside RT inhibitors (NRTIs) and non-nucleoside RT inhibitors
Table: L210W
Figure: Frequency of resistance drug resistance mutations M184V, T215Y, L210W and T215C/D before, during and after treatment.


  Specific HIV-1 integrase polymorphisms change their prevalence in untreated versus antiretroviral-treated HIV-1-infected patients, all naive to integrase inhibitors.
 PMID: 20817922       2010       The Journal of antimicrobial chemotherapy
Abstract: Similarly, V165I and G163R mutations were associated with the RT resistance mutations F227L and M230L, respectively, and the T206S polymorphism was associated with the RT resistance mutation L210W.



Browser Board

 Co-occurred Entities




   Filtrator